[go: up one dir, main page]

WO2008139124A3 - Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations - Google Patents

Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations Download PDF

Info

Publication number
WO2008139124A3
WO2008139124A3 PCT/FR2008/050726 FR2008050726W WO2008139124A3 WO 2008139124 A3 WO2008139124 A3 WO 2008139124A3 FR 2008050726 W FR2008050726 W FR 2008050726W WO 2008139124 A3 WO2008139124 A3 WO 2008139124A3
Authority
WO
WIPO (PCT)
Prior art keywords
topical
pharmaceutical
parenteral application
same
preparation methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/050726
Other languages
English (en)
Other versions
WO2008139124A2 (fr
Inventor
Marc Moutet
Jean-Claude Yadan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to US12/599,645 priority Critical patent/US20100298249A1/en
Priority to EP08788214A priority patent/EP2155186A2/fr
Priority to CA002686511A priority patent/CA2686511A1/fr
Publication of WO2008139124A2 publication Critical patent/WO2008139124A2/fr
Publication of WO2008139124A3 publication Critical patent/WO2008139124A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L' invention concerne une composition pharmaceutique ou cosmétique pour application topique et/ou parentérale comprenant, dans un milieu physiologiquement acceptable, au moins un rétinoïde ou ses sels et dérivés, et au moins un inhibiteur de la dégradation de l'acide hyaluronique. L'invention s'applique en particulier en dermatologie humaine ou en chirurgie réparatrice.
PCT/FR2008/050726 2007-05-11 2008-04-22 Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations Ceased WO2008139124A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/599,645 US20100298249A1 (en) 2007-05-11 2008-04-22 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
EP08788214A EP2155186A2 (fr) 2007-05-11 2008-04-22 Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
CA002686511A CA2686511A1 (fr) 2007-05-11 2008-04-22 Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755026 2007-05-11
FR0755026 2007-05-11

Publications (2)

Publication Number Publication Date
WO2008139124A2 WO2008139124A2 (fr) 2008-11-20
WO2008139124A3 true WO2008139124A3 (fr) 2009-02-05

Family

ID=38786904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/050726 Ceased WO2008139124A2 (fr) 2007-05-11 2008-04-22 Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations

Country Status (4)

Country Link
US (1) US20100298249A1 (fr)
EP (1) EP2155186A2 (fr)
CA (1) CA2686511A1 (fr)
WO (1) WO2008139124A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4578500A3 (fr) * 2010-12-23 2025-09-17 Amazentis SA Compositions et procédés pour améliorer la fonction mitochondriale et traiter des maladies neurodégénératives et des troubles cognitifs
JP6422163B2 (ja) * 2012-06-27 2018-11-14 アマゼンティス エスアーＡｍａｚｅｎｔｉｓ Ｓａ ウロリチンまたはその前駆体の投与によるオートファジーの増強または寿命の延長

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723139A (en) * 1996-09-27 1998-03-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing a polycyclic triterpene carboxylic acid and a retinoid
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6024941A (en) * 1992-07-13 2000-02-15 Shiseido Company, Ltd. External skin treatment composition
EP1023897A2 (fr) * 1999-01-26 2000-08-02 Showa Denko Kabushiki Kaisha Agent dermatologique
KR20010001290A (ko) * 1999-06-03 2001-01-05 서경배 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
WO2001085129A2 (fr) * 2000-05-05 2001-11-15 Johnson & Johnson Consumer Companies, Inc. Composition pour le soin de la peau
WO2002002074A2 (fr) * 2000-06-30 2002-01-10 Unilever Plc Compositions pour le soin de la peau renfermant des composes qui reproduisent l'effet de l'acide retinoique sur la peau
WO2004000242A1 (fr) * 2002-06-25 2003-12-31 Cosmeceutic Solutions Pty Ltd Compositions cosmetiques topiques
EP1514536A1 (fr) * 2003-09-10 2005-03-16 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Compositions Topiques
WO2007074288A1 (fr) * 2005-12-21 2007-07-05 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US523139A (en) * 1894-07-17 Thread-package
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4879114A (en) * 1985-12-20 1989-11-07 Angio-Medical Corporation Lipids from omentum and methods for cosmetic use
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
WO2000038647A1 (fr) * 1998-12-23 2000-07-06 Esparma Gmbh Agents pour proteger la peau, contenant un melange de fragments produit par hydrolyse a partir d'acide hyaluronique
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024941A (en) * 1992-07-13 2000-02-15 Shiseido Company, Ltd. External skin treatment composition
US5723139A (en) * 1996-09-27 1998-03-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing a polycyclic triterpene carboxylic acid and a retinoid
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
EP1023897A2 (fr) * 1999-01-26 2000-08-02 Showa Denko Kabushiki Kaisha Agent dermatologique
KR20010001290A (ko) * 1999-06-03 2001-01-05 서경배 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물
WO2001085129A2 (fr) * 2000-05-05 2001-11-15 Johnson & Johnson Consumer Companies, Inc. Composition pour le soin de la peau
WO2002002074A2 (fr) * 2000-06-30 2002-01-10 Unilever Plc Compositions pour le soin de la peau renfermant des composes qui reproduisent l'effet de l'acide retinoique sur la peau
WO2004000242A1 (fr) * 2002-06-25 2003-12-31 Cosmeceutic Solutions Pty Ltd Compositions cosmetiques topiques
EP1514536A1 (fr) * 2003-09-10 2005-03-16 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Compositions Topiques
WO2007074288A1 (fr) * 2005-12-21 2007-07-05 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200146, Derwent World Patents Index; AN 2001-430654, XP002463273 *
FURUYA T ET AL: "BIOCHEMICAL CHARACTERIZATION OF GLYCYRRHIZIN AS AN EFFECTIVE INHIBITOR FOR HYALURONIDASE FROM BOVINE TESTIS", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, vol. 20, no. 9, September 1997 (1997-09-01), pages 973 - 977, XP001207776, ISSN: 0918-6158 *
GIRISH ET AL: "The magic glue hyaluronan and its eraser hyaluronidase: A biological overview", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, vol. 80, no. 21, 20 April 2007 (2007-04-20), pages 1921 - 1943, XP022036977, ISSN: 0024-3205 *

Also Published As

Publication number Publication date
US20100298249A1 (en) 2010-11-25
EP2155186A2 (fr) 2010-02-24
CA2686511A1 (fr) 2008-11-20
WO2008139124A2 (fr) 2008-11-20

Similar Documents

Publication Publication Date Title
WO2008148967A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008139123A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
IL206443A0 (en) Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices
WO2008134712A3 (fr) Utilisation d'inhibiteurs de la métalloprotéinase de la matrice pour les soins de la peau
WO2010045415A3 (fr) Compositions topiques d'ains comprenant un composant apportant des sensations
MY161895A (en) Dermal film-forming liquid formulations for drug release to skin
WO2008087348A3 (fr) Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle
HK1202448A1 (en) Topical formulation for administering a compound
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
JP2017514825A5 (fr)
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
WO2008148966A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008004165A3 (fr) Emploi de dérivés de c-glycoside en tant que principes actifs favorisant la desquamation
WO2009001209A8 (fr) Utilisation de conjugués d'acide d'hyaluronique dans le traitement local de maladies de peau hyperprolifératives
WO2004100893A3 (fr) Methodes de traitement d'affections inflammatoires a l'aide de ct-3 ou de ses analogues
ATE489936T1 (de) Zusammensetzung mit mindestens einem c-glycosid- derivat und mindestens einer hyaluronsäure sowie ihre kosmetische anwendung
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
WO2008114376A1 (fr) Composition inhibitrice de la mélanogenèse
EP2241573A3 (fr) Dérivés de peptides et composition cosmétique la comprenant
WO2007113531A8 (fr) Administration de médicament topique
WO2008139124A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2014049561A3 (fr) Composition orale pour l'accroissement de la tolérance de la peau suite à l'administration topique d'un composé rétinoïde
WO2008152334A3 (fr) Nouveaux dérivés d'acide 3-phenyl acrylique activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques
WO2009106555A3 (fr) Gel de sucralfate sterilise

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08788214

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008788214

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2686511

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12599645

Country of ref document: US